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ABSTRACT: Nafion formed on the surface of a boron-doped diamond
electrode allows for a chemosensing system for biotin. The modified electrode
is capable of oxidizing biotin and offers a detection limit of 5 nM, the average
normal level of biotin in blood plasma. The developed method was successfully
applied to determine biotin in human plasma samples and a popular health
product as two popular models.
■ INTRODUCTION
For the most part, the use of biotin (also known as coenzyme
R, vitamin H or B7) is limited to labeling studies of
biomolecules for diversified applications.1 As a stable and
small molecule (MW of 244.3 Da), biotin rarely alters the
function of resulting conjugated molecules. Biotin acts as a
catalyst for carboxylase enzymes.2 The adequate intake of
biotin for adults is 30−100 μg/day based on as estimated from
Food and Nutrition Board3 for health benefits such as
stimulating hair growth and treating certain medical conditions
including biotin deficiency (BTD), lipid disorders, diabetes,
and diabetic peripheral neuropathy.4−7 However, supra-
physiological consumption of biotin in a plethora of health
products results in its high concentration in blood. Free biotin
in patient samples is posing a serious threat to immunodiag-
nostics, as evident by the recent safety alert by the US Food
and Drug Administration (FDA).8 Free biotin can interfere
with the diagnostic results of assays employing biotin−avidin
interactions, by competing with the biotinylated recognition
element, thereby leading to false positives or false negatives.9
Thus, a rapid and inexpensive method for the determination of
biotin in patient samples is urgently needed. The level of biotin
might be used to correct for its interference in immunoassays
using the avidin−biotin chemistry. The current popular
method is based on 4-hydroxyazobenzene-2-carboxylic acid
which forms a reversible yellow-orange color complex with
avidin.10 This avidin-binding dye is stoichiometrically dis-
placed by biotin, leading to the subsequent absorption change,
which provides a basis for the assay.
There are only a few studies pertaining to direct electro-
analysis of biotin. Pioneering work, dating back over 40 years,
unravels an irreversible one-electron reduction of biotin at
−1.8 V, in dimethylformamide (DMF)−water solutions.11,12
The topic was revisited by Lauw et al. to investigate biotin
reduction at a platinum (Pt) surface, in DMF and
dimethylsulfoxide (DMSO) supported by the organic salt
tetrabutylammonium hexafluorophosphate (TBAPF).13 There-
in, biotin at 2 mM is reduced by one-electron to form a
carboxylate anion and dihydrogen in DMF and DMSO.13 This
behavior is more pronounced in DMF than DMSO with a Pt
electrode poised at −1.6 V versus Fc/Fc+ (Fc = Ferrocene) but
does not occur if glassy carbon is used as the electrode
material.13 This approach is not applicable for the assay of
biotin in aqueous samples because of the severe interference of
water, even in minute quantity, particularly at high positive or
negative potentials, as discussed later.
In general, biotin in foodstuffs and biological fluids can be
analyzed by bioassays, avidin−streptavidin-binding assays, or
fluorescent derivative assays.14 However, biotin metabolites
and analogs interfere with the assay, particularly for the avidin
assay as addressed later. For a specific analysis of biotin in the
presence of its metabolites, the sample must be subjected to
high-performance liquid chromatography−mass spectroscopy
(HPLC−MS) followed by avidin−streptavidin-binding as-
says.15 The former procedure is capable of separating biotin
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from its metabolites whereas the latter detects biotin as well as
its metabolites.
The boron-doped diamond (BDD) electrode has been
advocated here because of its low background current,
resistance to fouling, and broad potential window.16 Recent
reports have demonstrated its applicability for detection of
Pseudomonas quinolone signal, 2-heptyl-4-hydroxyquinoline,
pyocyanin,17−19 2-(2-hydroxyphenyl)-thiazole-4-carbaldehyde
(IQS),20 and barakacin21 as a molecular signature of
Pseudomonas aeruginosa. There are a number of analytical
techniques reported for biotin determination such as
spectrometry,22 polarography,12 thin-layer chromatography,23
capillary electrophoresis,24 and high-performance liquid
chromatography.25−27
This communication unravels a new strategy for specific
analysis of biotin based on its electrochemical oxidation of
biotin at the surface of a Nafion-modified BDD electrode in an
aqueous media. Two popular model systems: a natural product
and human blood plasma will be tested to validate the proof of
concept. In our opinion, there is no report which exploits such
features for the electroanalysis of biotin.
■ RESULTS AND DISCUSSION
Behavior of the Bare BDD Electrode. Considering the
limited aqueous solubility of biotin (0.2 mg/mL),28 the
experiment was first conducted using a bare BDD electrode
in acetonitrile (MeCN) supported by TBAPF. This organic
salt is highly soluble in MeCN and offers a very low current
background over a wide potential range. Furthermore, the high
miscibility of MeCN with water (40:60%, v/v) accommodates
the analysis of aqueous samples. In summary, both cyclic
voltammetry (CV) and amperometry i−t curve confirmed the
oxidation of biotin (also prepared in MeCN−TBAPF) at the
applied potential of +1.8 V with a detection limit (LOD) of 3
μM (Figure S1a,b). In contrast, there was significant
interference using aqueous biotin samples because of peaks
derived from oxygen evolution and solvent breakdown29
(Figure S1c). When the MeCN−TBAPF system was applied
to an aqueous biotin sample, the above LOD was no longer
attained. Even at water: electrolyte volume ratios below 1:50,
the adsorbed water onto the electrode (BDD−H2O) was
oxidized at high potentials (2H+ + 2e− + 1/2O2), as reflected
by a current that increased steadily at potentials beyond +1.8
V. This phenomenon of oxygen evolution via water hydrolysis
is well-known30 and limits the applied potential of most
metallic electrodes to below 0.8−0.9 V.
In MeCN, the released protons can exit into the reaction/
diffusion layer near the electrode surface and can be
accommodated by MeCN as a proton acceptor. Solvent
(MeCN and TBAPF) breakdown could also occur here,
resulting in further interference peaks. Indeed, the solvent
breakdown has been known at the Pt surface in a MeCN/tetra-
n-butylammonium tetrafluoroborate system,29 whereas BF4
−
acts as a fluorinating agent in MeCN at +2.0 V together with
the formation of HF.31
In this work, an attempt using a high negative potential for
the reduction of biotin was also not successful in the presence
of a small amount of water from the biotin sample at the BDD
electrode in MeCN−TBAPF. The CV exhibited a very high
and broad emerging peak at −1.8 V and a small peak at −2 V,
which overlapped with the biotin reduction peak (Figure S2).
These two peaks could be attributed to the reduction of water
adsorbed on BDD (H2O + e
− → 1/2H2 (gas) + OH
−). The
formed OH− has been known to react with MeCN to form
acetamide (CH3CO−NH2), resulting in the solvent break-
down as reported by Pons and Khoo32 which again could lead
to interfering peaks. Evidence pointing to acetamide formation
was provided by the presence of an IR peak at 1650 cm−1 on
an electrolyte sample taken after 30 cycles of voltammetry
(−2.5 to +2.5 V at 100 mV s−1), (Figure S3). The OH− could
also be formed from the reduction of dissolved oxygen,
involving two different pathways. Oxygen is reduced directly to
OH− by a four-electron transfer, via H−O2 as an intermediate
species, followed by two further electron-transfer processes to
Figure 1. CVs of biotin obtained by the Nafion-modified BDD electrode vs Ag/AgCl using (a) 0.2 M acetate buffer, pH 4; (b) 0.2 M phosphate
buffer, pH 2, a scan rate of 100 mV s−1; (c) the CV of the bare and Nafion-modified BDD electrodes at a scan rate of 50 mV s−1 and (d) EIS of the
bare and Nafion-modified BDD electrodes (inset: the modified Randles circuit). Fe (CN)6
4−/3− (10 mM) prepared in 0.1 M KCl.
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yield 4 × OH−.33 Alternatively, the hydride ion (H−) in the
solution is known to deprotonate MeCN to CH2−CN, which
then attacks another MeCN to form a dimer.29 Besides the
restriction of water, the MeCN−TBAF approach lacks the
detection sensitivity required for blood screening for biotin,
ranging from 35 nM to 2.02 μM after single doses of 1 mg or
100 mg.9
Performance of the Nafion Modified BDD Electrode.
The experiments were then performed in aqueous electrolytes
using 0.2 M phosphate buffers at pH 4 and pH 2. The Nafion
was drop-casted on the BDD electrode. A representative CV of
the Nafion-modified electrode with and without biotin is
shown in Figure 1a,b, which shows the emerging oxidation
peak of the biotin oxidation product(s). It is important to
mention that the band around +1.5 V is due to the phosphate
buffer in Figure 1b, whereas the acetate buffer does not induce
any band (Figure 1a). The polymeric structure of Nafion
contains a hydrophobic (CF2−CF2) backbone, along with two
oxygen atoms and a hydrophilic sulfonic acid (SO3
−) group,
which contributes to its electron-withdrawing effect. Thus,
Nafion displays both hydrophobic and ionic interactions with
the BDD surface to form a stable layer, as confirmed by CV
and electrochemical impedance spectroscopy (EIS) measure-
ments (Figure 1c,d). The parameters obtained for the bare and
Nafion-modified BDD electrodes using an equivalent circuit Rs
(Cdl(Rct Zw)) is shown in Table S1. The Nafion-modified BDD
electrode is reusable and required to be cleaned only in 0.5 M
H2SO4. The electrode was tested using the ferri/ferrocyanide
redox couple as described in Figure 1c,d. The BDD itself is
prepared by chemical vapor deposition with hydrogen gas and
thus is recognized to be hydrogen-terminated.16
A simple i−t curve poised at +1.8 V shown in Figure 2a
illustrated an LOD of <1 μM for biotin for the Nafion-
modified BDD electrode at pH 4. Remarkably, an estimated
LOD of 5 nM of biotin was obtained at pH 2, when the
Nafion-modified electrode was poised at +1.8 V (Figure 2b)
because of the lower and stable background current. Figure 2c
shows the performance of the Nafion-modified BDD electrode
at high concentrations of biotin, and the calibration curve of
biotin exhibited excellent linearity (R2 > 0.99) (Figure 2c
insert).
A premixed biotin−avidin or biotin−streptavidin sample
provoked no signal response (Figure 3a,b). Conversely, the
response signal of biotin decreased significantly when the
protein (avidin or streptavidin) was introduced to the
electrochemical cell, illustrating the formation of the biotin−
protein complex. It is well-known that avidin and streptavidin
possesses a hydrophobic cavity that binds four biotin
molecules irreversibly.34 There are many interesting works
on the oxidation and reduction of biotin. The oxidation
product of biotin by electrochemical oxidation is not known
and requires further investigation. The sulfur of biotin can be
oxidized by H2O2, oxone, and other strong oxidants to form
biotin sulfoxide35 and biotin sulfone.36 However, experimen-
tally, such reactions must be performed for several hours,
usually at elevated temperature. Using a strong reductant
(Raney nickel) was reported to reduce biotin to desthiobio-
tin.37 In a contrasting report, biotin is not activated by Raney
nickel and the tetrahydrofuran moiety of oxybiotin appears
quite robust.38 Bacterial degradation of biotin using a β
oxidative system39 drives oxidation of the valeric side chain,
before hydrolysis of the ureido ring to form bisnorbiotin and
teranorbiotin. Oxybiotin, an analog of biotin (O instead of S),
can be prepared from biotin by oxidation.40 In electrochemical
reduction, biotin is simply reduced by one-electron to
carboxylate anion and dihydrogen via a discharge of the
carboxylic acid at the Pt surface.13 In this context, it is difficult
to specify the oxidation product(s) produced by the modified
electrode protocol described herein. As mentioned earlier,
Nafion consists of a hydrophobic backbone and a hydrophilic
Figure 2. (a) i−t curve for LOD determination using 0.2 M acetate
buffer, pH 4. (b) i−t curve for LOD determination using 0.2 M
phosphate buffer, pH 2; 10 nM biotin [(b), insert]. (c) Calibration
curve of biotin. The detection was achieved on the Nafion-modified
BDD electrode vs Ag/AgCl, the potential was at +1.8 V, using 0.2 M
phosphate buffer, pH 2.
Figure 3. (a) i−t curve obtained following the sequential addition of
avidin and biotin. (b) i−t curve obtained following the sequential
addition of streptavidin and biotin. The detection was achieved on the
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sulfonic acid group. When the water content of the membrane
is increased, the proton simultaneously diffuses through a
polymer electrolyte membrane, and the Nafion membrane is
dehydrated due to the electroosmotic drag from hydronium
ion.41 Also, the rate of proton transport depends on the water
concentration.42 Thus, the initial step of electrochemical
oxidation using the Nafion-modified BDD electrode involves
the partial protonation of biotin at the sulfur of the
tetrahydrothiophene ring and possibly the CO of the ureido
group. Then, electrochemical oxidation of protonated biotin
results3 in a distinct possibility that the oxidation products
involves sulfoxide or sulfone groups,43,44 or even oxybiotin40 as
shown in Scheme 1. It should be noted that the oxidation
capability of the BDD system also leads to the possibility of
accessing biotin analogs with different biological activities
using electrochemical means and without recourse to atom-
uneconomic oxidizing agents.
Analytical Performance of the Chemosensor. The
chemosensing approach was then applied to the analysis of a
commercial health product with a high dose of biotin (900 μg)
together with other components. A simple measurement by the
i−t curve was sufficient to estimate biotin content, based on
the signal response invoked (Figure 4). A single biotin tablet
(900 μg) was dissolved in deionized water. The quantity of
biotin was estimated to be between 874 and 884 μg, compared
with 900 μg as specified by the manufacturer.
Immunoassays for biotin have been commercially available
using a microtiter plate coated with avidin or streptavidin. In
brief, the enzyme-labeled biotin and the biotin-containing
sample are added, which compete with each other for the
avidin binding sites. After the removal of unbound enzyme-
labeled biotin, a specific enzyme substrate is added to trigger
color change with a resulting absorbance change proportional
to the biotin concentration of the sample. However, the assay
is not specific for biotin because some known biotin analogs
also bind to the coating avidin−streptavidin.
The cross-reactivity is about 83% for biocytin 34.7% for
biotin-d-sulfoxide, 28.2% for biotin sulfone, 24.5% for biotin-l-
sulfoxide, and 5.5% compared with 100% for biotin.45 This
method is referred as the total avidin binding assay, that is,
biotin together with its analogs. Nevertheless, the assay should
be applicable for the analysis of biotin in food samples
considering the absence of such biotin analogs. However, the
biotin analogs are not negligible but account for half of the
total avidin-binding substances in human plasma.46 This
critical issue has pointed out who require hemodialysis from
the analysis of patients’ blood for biotins.47 Of notice is the
specific detection of biotin by the Nafion-modified BDD
electrode because the above biotin analogs are not oxidized at
this applied potential for the oxidation of biotin. Apparently,
the difference between the results obtained by the electrode
and the immunoassay reflects the level of the biotin analogs.
This finding leads to a significance application considering the
simplicity of rapidity of electrochemical analysis over HPLC
for separation of biotin from its metabolites.
The detection of biotin from blood and blood plasma serves
as an indicator of BTD and in some cases it is important for
the patients who are subjected to hemodialysis or under biotin
therapy with high dosage. Therefore, the modified electrode
was then applied to the plasma sample, a more challenging task
because of the presence of endogenous electroactive
compounds. Indeed, numerous human blood components
have been identified in this very complex matrix.48 The
commercial plasma sample exhibited several major differential
pulse voltammetry (DPV) peaks, illustrating the presence of
endogenous electroactive molecules including uric acid,
dopamine, and so forth. (Figure 5). Indeed, numerous
human blood components have been identified in this very
complex matrix.48 The two peaks obtained from plasma
samples were identified as dopamine and tryptophan (Figure
5B,C). Thus, the analysis of biotin in blood plasma samples
could not be realized by the simple i−t approach (Figure S4).
The plasma samples spiked with uric acid results in an
increased baseline signal (Figure S5), whereas the plasma
samples spiked with tyrosine resulted in a decreased signal
(Figure S6). Nevertheless, DPV enabled the detection of
spiked biotin in blood plasma samples in the presence of the
matrix interferences. However, colorimetric assays including
Elisa using the avidin−biotin chemistry will detect biotin and
biotin analogs, whereas our approach only detects biotin.
Therefore, the results of the two procedures are not
comparable, considering that the total metabolite concen-
tration is about 50% that of biotin. Of course, LC−MS, an
Scheme 1. Postulated Electrochemical Oxidation of Biotin
To Form Biotin Sulfone (1) or Biotin Sulfoxide (2) or
Oxybiotin (3)
Figure 4. i−t curve of 1 μM biotin tablet and 1 μM of the biotin
standard. The detection was achieved on the Nafion-modified BDD
electrode: +1.8 V vs Ag/AgCl, using 0.2 M phosphate buffer, pH 2.
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expensive lab-based laboratory, will be used to compare the
results obtained by the electrochemical sensor. This task is
underway in our laboratories to monitor the biotin levels in
patients’ blood, a separate topic in our future endeavor.
The detection selectivity and sensitivity of the Nafion-
modified BDD electrode deserves a brief comment here with
respect to the detection limit required in clinical chemistry.
Biotin plays an important role in the human organs, which
might serve as a BTD index. The clinical analysis of biotin will
involve over 50−60 patients from three different groups: male,
female, and young people because their respective biotin levels
are noticeably different and the blood level after the digestion
of biotin varies significantly. Of particular interest is the
beneficial effects of high-dose biotin therapy in progressive
multiple sclerosis (MS), the most common disabling neuro-
logical disease in young adults. Under biotin therapy, the biotin
concentration of an MS patient can reach 2.84 μM.49 A liquid
chromatography−tandem mass spectrometry method
(LCMS−MS) has been proven useful with a measuring
range of 20 nM to 12.3 μM. The electroanalysis with a
detection limit of micrometer could be useful to follow the
biotin level of MS patients under biotin therapy with high
dosage. The sample can be preconcentrated by solid-phase
extraction, a simple and fast step in analytical and clinical
chemistry.
■ CONCLUSIONS
Nafion formed a stable layer on the surface of a BDD electrode
and allowed for sensitive detection of biotin. In the absence of
Nafion, the nonaqueous approach using MeCN and a
conducting salt gave a poor detection limit. The BDD
electrode displayed a wide, usable potential window at pH 2
and was capable of oxidizing biotin, resulting in a detection
limit of 5 nM. This inexpensive and rapid method is of interest
for the analysis of biotin in various clinical, biological, and food
samples. As described previously, the high level of biotin
interferes with immunoassays based on the biotinylated
molecules, resulting in falsely increased or decreased test
results. This is a serious pending issue in the clinical diagnosis
of biomarkers and diversified important analytes. Together
with solid-phase extraction, this approach can deliver the
detection sensitivity as required in clinical chemistry.
■ EXPERIMENTAL SECTION
Chemicals. Sodium phosphate monobasic, phosphoric
acid, acetic acid, sodium acetate, biotin, potassium chloride,
Nafion perfluorinated resin (5%) in a mixture of lower
aliphatic alcohols, TBAPF, potassium hexacyanoferrate,
ethanol, acetonitrile (MeCN), methanol (CH3OH), plasma
from human, uric acid, tyrosine, dopamine, tryptophan, and
avidin from egg white were purchased from Sigma-Aldrich
(Dublin, Ireland), whereas streptavidin was purchased from
Thermo Fisher Scientific (Dublin, Ireland). Deionized water
(Millipore, Ireland) was utilized throughout the experiments,
and all chemicals were of the analytical grade. The biotin tablet
was obtained from a local pharmacy, marketed as Boots
(Nottingham, England): Beauty from within, biotin (Cork,
Ireland), containing 900 μg biotin, in addition to dicalcium
phosphate, cellulose, hydroxypropylmethyl cellulose, hydrox-
ypropyl cellulose, silicon dioxide, talc, magnesium stearate,
stearic acid, potassium aluminum silicate, and colors (titanium
dioxide, indigo carmine, and carmine). Human plasma was
prepared in deionized water. Then, the plasma was spiked with
100 μM biotin standard and incubated for 15 min. A blank
plasma sample (100 μL) was added to the electrochemical cell
containing 0.2 M phosphate buffer, pH 2, whereas the three
different volumes of the biotin-spiked plasma sample (100,
200, and 300 μL) was added to the electrochemixzcal cell
containing 0.2 M phosphate buffer, pH 2. To identify the
electroactive molecules in plasma samples, the plasma was
spiked with 100 μM uric acid, tyrosine, dopamine, and
tryptophan standard each.
Apparatus and Measurements. EIS measurement was
performed at room temperature using a CHI660C electro-
chemical workstation (CH Instrument, Austin, TX). DPV,
amperometric measurement i−t curve, and CV were used
during electrochemical measurements at ambient temperature
using a CHI1040A electrochemical workstation (CH Instru-
ment, Austin, TX). The electrochemical cell consists of the
BDD working electrode (Windsor Scientific, Slough Berkshire,
UK), a Pt wire counter electrode (Sigma-Aldrich, Dublin,
Ireland), and a silver chloride (Ag/AgCl/3 M KCl) reference
electrode (BASi Analytical Instruments, West Layette, IN).
The CV and ESI measurements were performed in 10 mM
K3Fe(CN)6
4−/3− supported by 0.1 M KCl. EIS was performed
with AC frequency ranged between 1 Hz and 100 kHz at +0.2
V.
Preparation of the Modified Electrodes. The BDD
electrode was polished using 0.3 and 0.05 μm alumina slurry
with wet Nylon and MasterTex papers, respectively, followed
by sonication in MeCN for 5 min and deionized water for 10
min. The Nafion-modified BDD electrode was obtained by
drop-casting 2 μL of Nafion solution (2 w/v %, prepared in
Figure 5. (A) DPVs obtained of a blank and spiked plasma sample
with biotin standard. (a) 100 μL blank plasma; (b) 100 μL (2 μM)
biotin-spiked plasma; (c) 200 μL (4 μM) biotin-spiked plasma; and
(d) 300 μL (6 μM) biotin-spiked plasma. (B) DPVs obtained of a
blank and spiked plasma sample with dopamine standard. (a) 200 μL
blank plasma; (b) 200 μL (4 μM) dopamine-spiked plasma; and (c)
400 μL (8 μM) dopamine-spiked plasma. (C) DPVs obtained of a
blank and spiked plasma sample with tryptophan standard. (a) 200 μL
blank plasma; (b) 200 μL (4 μM) tryptophan-spiked plasma; and (c)
400 μL (8 μM) tryptophan-spiked plasma. The detection was
achieved on the Nafion-modified BDD electrode using 0.2 M
phosphate buffer, pH 2.
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Cyclic voltammogram (CV), limit of detection (LOD)
of biotin, and water interference of the bare BDD
electrode in the TBAPF−MeCN electrolyte; CV of
biotin reduction in the TBAPF−MeCN electrolyte on
the bare BDD electrode; IR spectra of 0.2 M TBAPF in
MeCN contains 1% water after 30 cycles of
voltammetry; parameters obtained for the bare and
Nafion-modified BDD electrodes using an equivalent
circuit Rs (Cdl(Rct Zw)); i−t curve of the blood plasma
and the biotin-spiked blood plasma; differential pulse
voltammograms (DPVs) obtained for a blank and a
spiked plasma sample with a uric acid standard; and
DPVs obtained of a blank and a spiked plasma sample
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